Metlife Inc (NYSE:MET) declared a quarterly dividend on Wednesday, July 8th, RTT News reports. Investors of record on Tuesday, August 4th will be given a dividend of 0.46 per share by the financial services provider on Monday, September 14th. This represents a $1.84 dividend on an annualized basis and a yield of 4.86%. The ex-dividend date of this dividend is Monday, August 3rd.
Metlife has increased its dividend by an average of 10.5% annually over the last three years and has raised its dividend every year for the last 7 years. Metlife has a payout ratio of 34.3% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Metlife to earn $6.00 per share next year, which means the company should continue to be able to cover its $1.84 annual dividend with an expected future payout ratio of 30.7%.
MET opened at $37.85 on Friday. The business’s fifty day simple moving average is $37.09 and its 200 day simple moving average is $38.85. Metlife has a 52 week low of $22.85 and a 52 week high of $53.28. The stock has a market cap of $34.35 billion, a PE ratio of 6.10, a P/E/G ratio of 4.42 and a beta of 1.34. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.21.
A number of brokerages have recently issued reports on MET. Morgan Stanley raised their price objective on Metlife from $40.00 to $44.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Credit Suisse Group reduced their price objective on Metlife from $60.00 to $46.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Bank of America initiated coverage on Metlife in a research note on Monday, June 1st. They set a “buy” rating on the stock. Zacks Investment Research raised Metlife from a “sell” rating to a “hold” rating and set a $45.00 target price on the stock in a research note on Tuesday, June 9th. Finally, ValuEngine cut Metlife from a “sell” rating to a “strong sell” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $41.88.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
See Also: Terms to Better Understand Call Options
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.